Matthew Leckenby

Matthew Leckenby has a diverse work experience in the field of bacteriology and scientific research. Matthew is currently employed as a Senior Scientist at Bavarian Nordic since May 2023. Prior to this, they worked at Emergent BioSolutions from July 2019 to May 2023 as a Scientist in Bacteriology. From July 2014 to July 2019, Matthew worked at PaxVax, Inc. in the same role. Matthew also held the position of Scientist in Bacteriology at Crucell from August 2011 to July 2014. Before that, Matthew worked as a Scientist at Philip Morris International from July 2010 to March 2011. Matthew gained significant experience as a Senior Scientist at Cobra Biomanufacturing from August 2001 to June 2010. Additionally, Matthew briefly worked as a Senior Scientist at RecipharmCobra Biologics in 2010.

Matthew Leckenby attended the University of Geneva from 1994 to 1999, where they earned a Licence degree in Biology. Prior to their university education, Matthew attended Ecole Moser, but the specific years and the degree or field of study are not provided.